Ce site utilise des cookies afin que nous puissions vous fournir la meilleure expérience utilisateur possible. Les informations sur les cookies sont stockées dans votre navigateur et remplissent des fonctions telles que vous reconnaître lorsque vous revenez sur notre site Web et aider notre équipe à comprendre les sections du site que vous trouvez les plus intéressantes et utiles.
NEW DATA:
Hyaluronic Acid (HA) Treatments vs. Corticosteroids (CS) for Osteoarthritis Knee Pain. The HA Treatments Resulted in: Fewer Adverse Events, Fewer Opioid Prescriptions, and Lower Medical Costs
THE STUDY FOLLOWED PATIENTS FOR FOUR YEARS. KEY FINDINGS:
FEWER ADVERSE EVENTS with HA’s:
15% FEWER ADVERSE EVENTS in the HA cohort vs. the CS cohort. Translating to 38% LESS MEDICAL COSTS.47
FEWER OPIOID PRESCRIPTIONS
with HA’s
The HA cohort purchased less than half the number of prescriptions for opioids and other painkillers than the CS cohort.47
“We have long known that introducing HA treatments earlier in the continuum of care of knee OA patients provides pain relief and allows them to enjoy a more active lifestyle. Now we know that with the pain relief comes reduced total medical costs, fewer adverse events and a minimization of opioids and analgesics, which should interest clinicians and payers working with these patients.”
– Alessandra Pavesio, Senior Vice President and
Chief Science Officer, Bioventus